|
⚲
|
| Keyboard |
| Viking Global Opportunities Illiquid Investments Sub-Master
✚
|
|
|---|---|
| CIK # | 0001629482 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001629482] | |
| 4 | [0001629482] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Inhibrx Biosciences Inc INBX
Common Stock
|
2025-10-07 | Sell | 25,042 | $32.25 | 807,604 |
|
Inhibrx Biosciences Inc INBX
Common Stock
|
2025-10-07 | Sell | 308,643 | $32.25 | 9,953,737 |
|
Inhibrx Biosciences Inc INBX
Common Stock
|
2025-10-07 | Sell | 16,315 | $32.25 | 526,159 |
|
BridgeBio Pharma Inc BBIO
Common Stock
|
2025-06-27 | Sell | 3,500,000 | $44.00 | 154,000,000 |
|
BridgeBio Pharma Inc BBIO
Common Stock
|
2025-01-31 | Sell | 3,065,616 | $34.90 | 106,989,998 |
|
APi Group Corp APG
Common Stock
|
2024-06-17 | Sell | 39,032 | $38.15 | 1,489,071 |
|
APi Group Corp APG
Common Stock
|
2024-06-17 | Sell | 1,912,750 | $38.15 | 72,971,412 |
|
Inhibrx Inc INBX
Warrants (right to buy) · derivative
|
2024-05-30 | Other | 1,038,765 | $30.00 | 31,162,950 |
|
Inhibrx Inc INBX
Common Stock
|
2024-05-30 | Other | 6,305,866 | $30.00 | 189,175,980 |
|
Inhibrx Inc INBX
Common Stock
|
2024-05-30 | Other | 333,333 | $30.00 | 9,999,990 |
|
Inhibrx Inc INBX
Common Stock
|
2024-05-30 | Other | 511,627 | $30.00 | 15,348,810 |
|
APi Group Corp APG
Common Stock
|
2024-03-05 | Sell | 2,977,845 | $34.25 | 101,991,191 |
|
APi Group Corp APG
Common Stock
|
2024-03-05 | Sell | 60,772 | $34.25 | 2,081,441 |
|
APi Group Corp APG
Common Stock
|
2024-02-28 | Conversion | 8,036,862 | $24.60 | 197,706,805 |
|
APi Group Corp APG
Common Stock
|
2024-02-28 | Conversion | 164,016 | $24.60 | 4,034,794 |
|
APi Group Corp APG
Common Stock
|
2024-02-28 | Other | 3,983,739 | $36.90 | 146,999,969 |
|
APi Group Corp APG
Common Stock
|
2024-02-28 | Other | 81,300 | $36.90 | 2,999,970 |
|
APi Group Corp APG
5.5% Series B Perpetual Convertible Preferred Stock · derivative
|
2024-02-28 | Conversion | 196,000 | $0.00 | |
|
APi Group Corp APG
5.5% Series B Perpetual Convertible Preferred Stock · derivative
|
2024-02-28 | Conversion | 4,000 | $0.00 | |
|
RayzeBio Inc RYZB
Common Stock
|
2024-02-26 | Other | 4,899,144 | ||
| showing 20 of 156 most recent transactions | |||||